149 related articles for article (PubMed ID: 8722708)
1. Characterization of binding sites for beta-adrenergic agonists and vasoactive intestinal peptide in the rat harderian gland.
Guerrero JM; Osuna C; Molinero P; Caraballo MI; Harmouch A; Pozo D; Rafii-el-Idrissi M; Garcia-Macias JF; Calvo JR
Microsc Res Tech; 1996 Jun; 34(2):139-43. PubMed ID: 8722708
[TBL] [Abstract][Full Text] [Related]
2. Binding of [125I]iodocyanopindolol by rat harderian gland crude membranes: kinetic characteristics and day-night variations.
Harmouch A; Osuna C; Rafii-el-Idrissi M; Calvo JR; Guerrero JM
Biosci Rep; 1996 Oct; 16(5):369-77. PubMed ID: 8913527
[TBL] [Abstract][Full Text] [Related]
3. VIP receptor-effector system in rat harderian gland and its coupling to activation of type II thyroxine 5'-deiodinase.
Calvo JR; Caraballo MI; Pozo D; Segura JJ; Osuna C; Guerrero JM
Peptides; 1995; 16(3):551-7. PubMed ID: 7651912
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of receptors for VIP in rat peritoneal macrophage membranes.
Calvo JR; Guerrero JM; López-Gonzalez MA; Osuna C; Segura JJ
Peptides; 1994; 15(2):309-15. PubMed ID: 8008637
[TBL] [Abstract][Full Text] [Related]
5. Characterization of vasoactive intestinal peptide receptors in rat seminal vesicle.
Guijarro LG; Rodriguez-Pena MS; Prieto JC
Am J Physiol; 1991 Feb; 260(2 Pt 1):E286-91. PubMed ID: 1847588
[TBL] [Abstract][Full Text] [Related]
6. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
Sakakibara H; Shima K; Said SI
Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252
[TBL] [Abstract][Full Text] [Related]
7. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
8. Expression of VIP receptors in mouse peritoneal macrophages: functional and molecular characterization.
Calvo JR; Montilla ML; Guerrero JM; Segura JJ
J Neuroimmunol; 1994 Feb; 50(1):85-93. PubMed ID: 8300860
[TBL] [Abstract][Full Text] [Related]
9. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
Laburthe M; Couvineau A; Rouyer-Fessard C
Mol Pharmacol; 1986 Jan; 29(1):23-7. PubMed ID: 3003561
[TBL] [Abstract][Full Text] [Related]
10. Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages.
Segura JJ; Guerrero JM; Goberna R; Calvo JR
Regul Pept; 1991 Apr; 33(2):133-43. PubMed ID: 1652777
[TBL] [Abstract][Full Text] [Related]
11. Characterization of VIP-and helodermin-preferring receptors on rat platelets.
Shima K; Sakakibara H; Said SI
Regul Pept; 1996 Jul; 63(2-3):99-103. PubMed ID: 8837217
[TBL] [Abstract][Full Text] [Related]
12. Characterization of vasoactive intestinal peptide receptors in human liver.
Rodríguez-Henche N; Rodríguez-Pena MS; Guijarro LG; Prieto JC
Biochim Biophys Acta; 1994 Mar; 1221(2):193-8. PubMed ID: 8148398
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenergic receptors in the rat mammary gland during pregnancy and lactation: characterization, distribution, and coupling to adenylate cyclase.
Marchetti B; Fortier MA; Poyet P; Folléa N; Pelletier G; Labrie F
Endocrinology; 1990 Jan; 126(1):565-74. PubMed ID: 2152873
[TBL] [Abstract][Full Text] [Related]
14. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
15. Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes.
Guerrero JM; Prieto JC; Ramírez-Cárdenas R; Calvo JR; Goberna R
Rev Esp Fisiol; 1981 Mar; 37(1):1-8. PubMed ID: 6113623
[TBL] [Abstract][Full Text] [Related]
16. VIP receptor subtypes in mouse cerebral cortex: evidence for a differential localization in astrocytes, microvessels and synaptosomal membranes.
Martin JL; Feinstein DL; Yu N; Sorg O; Rossier C; Magistretti PJ
Brain Res; 1992 Jul; 587(1):1-12. PubMed ID: 1326373
[TBL] [Abstract][Full Text] [Related]
17. Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes.
Wanke IE; Rorstad OP
Endocrinology; 1990 Apr; 126(4):1981-8. PubMed ID: 2156675
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the immunomodulatory properties of the secretin-glucagon family of peptides on mouse lymphoid cell functions and the demonstration of specific receptors on T cells.
Nguyen TT; Krco CJ; Gores A; Go VL
Immunol Invest; 1987 Nov; 16(7):555-77. PubMed ID: 2832322
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide binding to specific receptors on rat parotid acinar cells induces amylase secretion accompanied by intracellular accumulation of cyclic adenosine 3'-5'-monophosphate.
Inoue Y; Kaku K; Kaneko T; Yanaihara N; Kanno T
Endocrinology; 1985 Feb; 116(2):686-92. PubMed ID: 2578385
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68.
Van Valen F; Jürgens H; Winkelmann W; Keck E
Cell Signal; 1989; 1(5):435-46. PubMed ID: 2561912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
